IKZF3 and cutaneous melanoma: In the field of solid tumours, bioinformatics-based research has demonstrated that IKZF3 serves as an independent prognostic factor for both skin melanoma (SKCM) and human head and neck squamous cell carcinoma (HNSCC) (Li et al. 2023; Yang et al. 2022), suggesting its potential as a promising target for immunotherapy in the treatment of SKCM and HNSCC.